We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.3M
AUM Growth
-$6.56M
Cap. Flow
-$10.2M
Cap. Flow %
-17.49%
Top 10 Hldgs %
64.28%
Holding
47
New
7
Increased
6
Reduced
18
Closed
13

Top Buys

Rank Stock Value
1
RNF
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
+$1.56M
2
UI icon
Ubiquiti
UI
+$935K
3
BCPC
Balchem Corp
BCPC
+$441K
4
SANW
S&W Seed Co
SANW
+$389K
5
SMSI icon
Smith Micro Software
SMSI
+$374K

Top Sells

Rank Stock Value
1
CYNO
Cynosure, Inc. Class A
CYNO
+$2.46M
2
BEAT
BioTelemetry, Inc.
BEAT
+$2.27M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$1.7M
4
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$1.49M
5
CSII
Cardiovascular Systems, Inc.
CSII
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 37.45%
2 Technology 24.02%
3 Utilities 9.66%
4 Materials 9.34%
5 Communication Services 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANW
26
DELISTED
S&W Seed Co
SANW
$395K 0.68%
+4,505
New +$389K
TPST icon
27
Tempest Therapeutics
TPST
$17.9M
$323K 0.55%
3
-3
-50% -$399K
DAR icon
28
Darling Ingredients
DAR
$9.69B
$298K 0.51%
+21,200
New +$349K
CCC
29
DELISTED
Calgon Carbon Corp
CCC
$289K 0.5%
+13,700
New +$277K
TNGO
30
DELISTED
Tangoe, Inc.
TNGO
$250K 0.43%
+18,100
New +$223K
LMNR icon
31
Limoneira
LMNR
$246M
$135K 0.23%
+6,200
New +$134K
RVLT
32
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$82K 0.14%
7,414
-114
-2% -$1.32K
CVGW
33
DELISTED
Calavo Growers
CVGW
$44K 0.08%
+850
New +$38K
OPWR
34
DELISTED
OPOWER INC COM STK (DE)
OPWR
$40K 0.07%
+3,900
New +$47.6K
ALT icon
35
Altimmune
ALT
$630M
– –
-1,667
Closed -$903K
CLRB icon
36
Cellectar Biosciences
CLRB
$24M
– –
-5
Closed -$441K
GENC icon
37
Gencor Industries
GENC
$280M
– –
-18,225
Closed -$114K
GTLS
38
DELISTED
Chart Industries
GTLS
– –
-875
Closed -$30K
LNG icon
39
Cheniere Energy
LNG
$58B
– –
-1,400
Closed -$99K
REFR icon
40
Research Frontiers
REFR
$16.9M
– –
-81,629
Closed -$418K
SLB icon
41
SLB Ltd
SLB
$81.6B
– –
-1,200
Closed -$102K
GLOG
42
DELISTED
GASLOG LTD
GLOG
– –
-2,000
Closed -$41K
P
43
DELISTED
Pandora Media Inc
P
– –
-41,100
Closed -$734K
CYNO
44
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-89,700
Closed -$2.46M
CEMI
45
DELISTED
Chembio diagnostics, Inc.
CEMI
– –
-103,400
Closed -$407K
MCUR
46
DELISTED
Macrocure Ltd.
MCUR
– –
-20,000
Closed -$146K
1
2

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Sophrosyne Capital held 47 positions worth $58.3M, down 10% from $64.8M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sophrosyne Capital withdrew a net $10.2M in Q1 2015, closing 13 positions and reducing 18 holdings. Its most notable exit was Cynosure, Inc. Class A, an estimated $2.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 50% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sophrosyne Capital opened a new position in S&W Seed Co worth $395K.

  • Sophrosyne Capital's largest Q1 2015 buy was S&W Seed Co: 4,505 shares worth $395K.
  • Sophrosyne Capital added most to RENTECH NITROGEN PARTNERS, L.P. INT in Q1 2015, an estimated $1.56M increase.
  • Sophrosyne Capital's biggest Q1 2015 reduction was BioTelemetry, Inc., cutting an estimated $2.27M.
  • Sophrosyne Capital fully exited Cynosure, Inc. Class A in Q1 2015, selling an estimated $2.46M.
  • Sophrosyne Capital's ten largest holdings make up 64% of its $58.3M portfolio in Q1 2015.
  • Sophrosyne Capital opened 7 new positions and closed 13 in Q1 2015.
  • Sophrosyne Capital's portfolio value fell 10% quarter-over-quarter to $58.3M.

Based on Sophrosyne Capital's 13F filing for Q1 2015, filed 20 Apr 2015.